Unknown statusObservationalLast updated Apr 19, 2023

Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies

Radiomic Analysis of CT and MRI Scans for Predicting Treatment Response and Clinical Outcomes in Patients With Breast, Brain, Head-neck and Gynecological Malignancies

Overview

ClinicalTrials.gov ID: NCT05170087
Lead Sponsor: Sunnybrook Health Sciences CentreOTHER
Brief Summary: In this study, the investigators aim to undertake a retrospective analysis of CT and MRI scans for patients undergoing radiation treatment to develop radiomic signatures to predict treatment response and clinical outcomes.
Study Type: Observational

Status

Overall Status: Unknown status
Start Date: Mar 2, 2020Actual
Primary Completion Date: Mar 2025Estimated
Completion Date: Mar 2025Estimated

Study Record Dates

First Submitted: Nov 23, 2021
First Submitted that Met QC Criteria: Dec 10, 2021
First Posted: Dec 27, 2021Actual
Last Update Submitted that Met QC Criteria: Apr 17, 2023
Last Update Posted: Apr 19, 2023Actual
Last Verified: Apr 2023

NCT04079283Completed

Radiomics of Immunotherapeutics Response Evaluation and Prediction

NCT03709186Completed

Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI

NCT04197297Recruiting

Brain Imaging Biomarkers in Patients With Brain Metastasis

NCT04021069Unknown status

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

NCT03592004Unknown status

Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer

NCT01302626Completed

Radiomics: a Study of Outcome in Lung Cancer